CeCors Financials
| CEOS Stock | USD 0.03 0 11.85% |
CeCors |
Understanding current and past CeCors Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CeCors' financial statements are interrelated, with each one affecting the others. For example, an increase in CeCors' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CeCors' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CeCors Inc. Check CeCors' Beneish M Score to see the likelihood of CeCors' management manipulating its earnings.
CeCors Stock Summary
CeCors competes with GlucoTrack, Sharps Technology, Avinger, Utah Medical, and Predictive Oncology. Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. CECORS INC operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 17 Belfield Road, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.psykeyworld.com |
| Phone | 888 376 8258 |
| Currency | USD - US Dollar |
CeCors Key Financial Ratios
There are many critical financial ratios that CeCors' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CeCors Inc reports annually and quarterly.| Return On Equity | -7.26 | |||
| Return On Asset | -1.8 | |||
| Beta | 0.11 | |||
| Z Score | -24.3 |
CeCors Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CeCors's current stock value. Our valuation model uses many indicators to compare CeCors value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CeCors competition to find correlations between indicators driving CeCors's intrinsic value. More Info.CeCors Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CeCors' earnings, one of the primary drivers of an investment's value.CeCors Inc Systematic Risk
CeCors' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CeCors volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on CeCors Inc correlated with the market. If Beta is less than 0 CeCors generally moves in the opposite direction as compared to the market. If CeCors Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CeCors Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CeCors is generally in the same direction as the market. If Beta > 1 CeCors moves generally in the same direction as, but more than the movement of the benchmark.
CeCors December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CeCors help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CeCors Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of CeCors Inc based on widely used predictive technical indicators. In general, we focus on analyzing CeCors Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CeCors's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.97 | |||
| Information Ratio | 0.0502 | |||
| Maximum Drawdown | 81.48 | |||
| Value At Risk | (13.16) | |||
| Potential Upside | 27.03 |
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.